ROBERT GRIGG: Open Payments
NPI 1407371941 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 52 payments from 16 companies in 2025. Trend: 2023 $1,346 · 2024 $1,385 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $204 |
| AstraZeneca Pharmaceuticals LP | 2 | $160 |
| Amgen Inc. | 11 | $145 |
| Dexcom, Inc. | 3 | $87 |
| Novo Nordisk Inc | 4 | $75 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Exact Sciences Corporation | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $29 |
Products named: AIRSUPRA, LINZESS, Dexcom G6 Transmitter, CREON, OTEZLA, EVENITY, Rybelsus, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
